HC Wainwright Reiterates Buy Rating for Atyr PHARMA (NASDAQ:ATYR)
Atyr PHARMA (NASDAQ:ATYR – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $35.00 target price on the stock. Several other brokerages have also issued reports on ATYR. Leerink Partners initiated coverage on Atyr PHARMA in a report […]
Atyr PHARMA (NASDAQ:ATYR – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $35.00 target price on the stock. Several other brokerages have also issued reports on ATYR. Leerink Partners initiated coverage on Atyr PHARMA in a report […]
